EU Guide Outlines Important Considerations For Submitting Complex Trials In CTIS
Executive Summary
EU regulators have issued a new Q&A document on the key aspects that sponsors of complex trials should consider when making new submissions or moving ongoing studies to the Clinical Trials Information System.